British Journal of Oral and Maxillofacial Surgery
Volume 44, Issue 6 , Pages 482-486, December 2006

The matrix metalloproteinase system in oral squamous cell carcinoma

  • E.A. Baker

      Affiliations

    • Professorial Unit of Surgery, University Hospital of North Tees, Stockton on Tees TS19 8PE, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 1642 624163; fax: +44 1642 624165.
  • ,
  • D.J. Leaper

      Affiliations

    • Professorial Unit of Surgery, University Hospital of North Tees, Stockton on Tees TS19 8PE, UK
  • ,
  • J.P. Hayter

      Affiliations

    • Maxillofacial Unit, University Hospitals of Leicester, Leicester Royal Infirmary, Leicester, UK
  • ,
  • A.J. Dickenson

      Affiliations

    • Maxillofacial Unit, Derbyshire Royal Infirmary, Derby, UK

Accepted 13 October 2005.

Abstract 

Background

The matrix metalloproteinase (MMP) system is responsible for degradation of tissue in both normal and pathological processes, including tumour invasion and metastasis.

Aim

To compare tissue concentrations of components of the MMP system between tumour tissue and normal tissue in patients with oral squamous cell carcinoma, and to correlate concentrations with pathological grade of tumour.

Methods

Thirty-eight paired tissue samples from tumours and normal tissue were analysed by three laboratory techniques: firstly, enzyme linked immunosorbent assays (ELISA) in ng/mg protein for MMP-1, MMP-3, and tissue inhibitors of metalloproteinases (TIMPs) -1 and -2. Secondly, gelatinase activity assays to measure concentrations of total and endogenous active gelatinases, MMP-2 and MMP-9 (ng/mg protein). And thirdly to use quenched fluorescent substrate hydrolysis to measure total MMP activity (pM/min).

Results

The concentration of all MMPs was significantly higher in tumour than in normal oral tissue (p<0.05, Mann–Whitney U-test). Tissue concentrations of some of these factors correlated with clinical and pathological indices of aggressiveness of tumours, including T-stage, N-stage, tumour differentiation, and anatomical level of involved nodes. However, the study was not powered to show statistical significance.

Conclusion

It is the balance between proteinases and their inhibitors that controls tissue degradation at each stage of tumour invasion and metastasis. Measurement of MMPs in oral mucosal biopsy samples may establish the invasive potential of tumours at their initial presentation.

Keywords: Head and neck cancer, Tissue inhibitors of metalloproteinase (TIMP), Proteinases, Proteinase inhibitors, Metastasis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0266-4356(05)00322-0

doi:10.1016/j.bjoms.2005.10.005

British Journal of Oral and Maxillofacial Surgery
Volume 44, Issue 6 , Pages 482-486, December 2006